Publications by authors named "Yasuko Nezu"

Claim this Profile
E
Effectiveness of screening endoscopy for esophageal squamous cell carcinoma in Japanese males.
Yasuko Nezu, Noriaki Manabe, Yoshioki Yoda, Ken Haruma

United European Gastroenterol J· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction in asthma exacerbation rate after mepolizumab treatment initiation in patients with severe asthma: A real-world database study in Japan.
Hiroyuki Nagase, Jun Tamaoki, Takeo Suzuki, Yasuko Nezu, Shoko Akiyama

Pulm Pharmacol Ther· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of mepolizumab in severe asthma in Japan: A real-world study using claims data.
Hiroyuki Nagase, Jun Tamaoki, Takeo Suzuki, Yasuko Nezu, Masayuki Katsumata

Clin Transl Allergy· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The IMPACT Study - Single Inhaler Triple Therapy (FF/UMEC/VI) Versus FF/VI And UMEC/VI In Patients With COPD: Efficacy And Safety In A Japanese Population.
Motokazu Kato, Keisuke Tomii, Kenichi Hashimoto, Yasuko Nezu, Takeo Ishii

Int J Chron Obstruct Pulmon Dis· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pseudoaneurysm caused by a self-expandable metal stent: a report of three cases.
Yasuko Nezu, So Nakaji, Hiroyuki Fujii, Eiji Ishii, Nobuto Hirata

Endoscopy· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1α,25-Dihydroxyvitamin D3 enhances cerebral clearance of human amyloid-β peptide(1-40) from mouse brain across the blood-brain barrier.
Shingo Ito, Sumio Ohtsuki, Yasuko Nezu, Yusuke Koitabashi, Sho Murata

Fluids Barriers CNS· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebral clearance of human amyloid-beta peptide (1-40) across the blood-brain barrier is reduced by self-aggregation and formation of low-density lipoprotein receptor-related protein-1 ligand complexes.
Shingo Ito, Sumio Ohtsuki, Junichi Kamiie, Yasuko Nezu, Tetsuya Terasaki

J Neurochem· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis